Desvenlafaxine
Desvenlafaxine is listed in the FDA National Drug Code directory with 27 NDC codes, marketed under brand name including Desvenlafaxine. Available dosage forms: tablet, extended release, tablet, film coated, extended release, powder.
Drug Details
- Generic Name
- Desvenlafaxine
- Brand Names
- Desvenlafaxine
- Application Number
- ANDA204065
- Sponsor
- Actavis Pharma, Inc.
- NDC Codes
- 27
- Dosage Forms
- TABLET, EXTENDED RELEASE, TABLET, FILM COATED, EXTENDED RELEASE, POWDER
- Routes
- ORAL
- Active Ingredients
- DESVENLAFAXINE SUCCINATE, DESVENLAFAXINE
Indications and Usage
1 INDICATIONS AND USAGE Desvenlafaxine extended-release tablet is indicated for the treatment of adults with major depressive disorder (MDD) [see CLINICAL STUDIES ( 14 )]. Desvenlafaxine extended-release tablet, is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).